Edition:
United States

Integer Holdings Corp (ITGR.N)

ITGR.N on New York Stock Exchange

83.40USD
24 Sep 2018
Change (% chg)

$-0.40 (-0.48%)
Prev Close
$83.80
Open
$83.60
Day's High
$83.70
Day's Low
$82.90
Volume
41,116
Avg. Vol
58,694
52-wk High
$84.20
52-wk Low
$42.50

Summary

Name Age Since Current Position

Bill Sanford

74 2008 Independent Chairman of the Board

Joseph Dziedzic

49 2017 President, Chief Executive Officer, Director

Jeremy Friedman

63 2018 Chief Financial Officer, Chief Operating Officer, Executive Vice President

Jennifer Bolt

49 2015 President, Electrochem

Antonio Gonzalez

44 2015 President, CRM & Neuromodulation

Payman Khales

48 2018 President - Cardio and Vascular Product Line

Declan Smyth

47 2015 President, Advanced Surgical & Orthopedics

Kirk Thor

54 2018 Chief Human Resource Officer, Executive Vice President

Michael Spencer

48 Senior Vice President, Chief Ethics & Compliance Officer

Timothy McEvoy

60 2014 Senior Vice President, General Counsel, Secretary

Tommy Thomas

47 2018 Vice President & Corporate Controller

Pamela Bailey

69 2002 Independent Director

James Hinrichs

50 2018 Independent Director

Jean Hobby

57 2015 Independent Director

Martin Maxwell

59 2015 Independent Director

Filippo Passerini

60 2015 Independent Director

Peter Soderberg

71 2002 Independent Director

Donald Spence

63 2016 Independent Director

William Summers

67 2001 Independent Director

Tony Borowicz

2018 VP, Strategy, Business Development

Biographies

Name Description

Bill Sanford

Mr. Bill R. Sanford is Independent Chairman of the Board of Integer Holdings Corp. Mr. Sanford is Chairman of Symark LLC, a company he founded in 1979 that focuses on the development and commercialization of medical devices, bioscience inventions, nanotechnology, and advanced technology systems, products and services. He has broad experience as a board member and advisor of numerous public and private for-profit companies, not-for-profit organizations, investment limited partnerships and venture capital firms. Mr. Sanford is Executive Founder and retired Chairman, President and Chief Executive Officer of Steris Corporation, retired director of KeyCorp and KeyBank N.A., trustee of Cleveland Clinic, trustee emeritus of Case Western Reserve University and Kansas State University, former director of AdvaMed, and a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

Joseph Dziedzic

Mr. Joseph W. Dziedzic serves as President, Chief Executive Officer, Director of Greatbatch, Inc. He Prior to being appointed as the Company’s Interim President and Chief Executive Officer, Mr. Dziedzic served as Chair of the Audit Committee and a member of the Compensation and Organization Committee. From 2009 to 2016, Mr. Dziedzic was the Executive Vice President and Chief Financial Officer of The Brink’s Company, a global leader in security-related services for banks, retailers and a variety of other commercial and governmental customers. Prior to joining The Brink’s Company in 2009, he had a 20-year career with General Electric, including leadership roles in six different businesses, including General Electric Medical Systems.

Jeremy Friedman

Mr. Jeremy A. Friedman is Interim Chief Financial Officer of the Company. In this newly established role, Mr. Friedman has responsibility for the Company's Advanced Surgical & Orthopedic, Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation product categories as well as the Supply Chain, Lean Enterprise, and Enterprise Health, Safety & Security functions. Jeremy brings tremendous knowledge and experience to this role, having previously served as COO for a subsidiary of one of the world's largest contract manufacturing companies, where he led the turnaround of a business comprised of 10,000 employees in 17 countries,” said Thomas J. Hook, Integer’s president and CEO. “He is charged with leading our company through the largest acquisition in our history, making us one of the largest medical device outsource manufacturers in the industry. Jeremy will apply his in-depth understanding of lean principles to maximize our integration efforts and strengthen our position in the marketplace. Mr. Friedman has been with the company since 2007, most recently serving as President of the Cardio & Vascular product category. Prior to that he held numerous finance and operating executive leadership roles – including three previous COO positions in a variety of industries. He holds an MBA from Harvard University with a concentration in Finance and General Management and a bachelor’s degree from Haverford College.

Jennifer Bolt

Ms. Jennifer M. Bolt is President, Electrochem of the Company. In November 2017, Ms. Bolt assumed leadership of the Power Solutions product line, and in February 2018, she assumed leadership for the Integer Manufacturing Excellence strategic imperative. From June 2013 to October 2015 she was Vice President, Supply Chain and Operational Excellence for Greatbatch. Ms. Bolt held the position of Vice President, Operations for Electrochem from May 2012 to June 2013, and prior to that served as Director of Operations of our Raynham, MA facility from September 2007 to May 2012. Ms. Bolt joined our Company in May 2005 as the Manufacturing Engineering Manager for our Alden, NY facility. Prior to joining our Company, she served in a variety of engineering and operational roles at General Motors/Delphi and Eastman Kodak.

Antonio Gonzalez

Mr. Antonio Gonzalez is President, CRM & Neuromodulation of the Company. From October 2014 to October 2015, he served as Vice President, Operations, Greatbatch Medical Mexico. Previously, Mr. Gonzalez served as Executive Director, Operations Mexico between November 2011 and October 2014, Director of Global Supply Chain from November 2007 to November 2011, Director of Strategic Projects from March 2006 to November 2007, and Supply Chain Manager for Greatbatch Tecnologías de Mexico from January 2005 to March 2006. Prior to joining our Company, he served in a variety of finance, operations, supply chain and customer management roles with Sanmina-SCI, BellSouth Telecommunications, HSBC and ING Bank.

Payman Khales

Mr. Payman Khales is President - Cardio and Vascular Product Line of the Company. Prior to joining Integer, Mr. Khales was the President of the Environmental Technologies Segment at CECO Environmental Company from May 2014 through July 2017. Previously, he was employed by Ingersoll Rand Company where he held a variety of different roles in the United States and Canada, including Vice-President Product Management for the global Power Tools division from January 2012 through April 2014, and Vice-President Strategic Accounts & Channels from February 2010 through December 2011.

Declan Smyth

Mr. Declan Smyth is President, Advanced Surgical & Orthopedics of the Company. From January 2013 until the Company’s acquisition of Lake Region Medical in October 2015, he was President of Lake Region Medical’s Advanced Surgical business. From January 2012 to January 2013, he was Strategic Product Leader of Surgical Devices and Diagnostics at Accellent, Inc. and prior to that served as Senior Director of Engineering at Accellent, Inc. from August 2009 to January 2012.

Kirk Thor

Mr. Kirk Thor is Executive Vice President and Chief Human Resources Officer of the Company. From 2013 until joining the Company in January 2018, Mr. Thor was Vice President for Global Talent Management & Organization Effectiveness at Flowserve Corporation. From 2007 to 2012, he served as Vice President for Talent Management & Organization Development at JC Penney. In February 2018, he assumed leadership for the Integer Culture strategic imperative.

Michael Spencer

Mr. Michael L. Spencer is Senior Vice President, Chief Ethics & Compliance Officer of the Integer Holdings Corp. Prior to joining the Company in October 2015, Mr. Spencer was Chief Ethics and Compliance Officer of Orthofix Inc. where he had served since August of 2013. Prior to that, between 2001 and 2013, he served as Ethics and Compliance Officer for the Smith and Nephew Advanced Surgical Division.

Timothy McEvoy

Mr. Timothy G. McEvoy is Senior Vice President, General Counsel & Secretary of the Company. since joining our Company in February 2007. From 1992 until January 2007, he was employed in a variety of legal roles by Manufacturers and Traders Trust Company.

Tommy Thomas

Mr. Tommy P. Thomas is appointed as Vice President & Corporate Controller of theInteger Holdings Corp effective as of February 5, 2018. In his position, Mr. Thomas will serve as the principal accounting officer of the Company. Since 2005, Mr. Thomas has served in a number of financial roles with Windstream, Inc., a network communications and technology service provider, and its predecessor companies, including as Chief Financial Officer and Vice President, Small Business and Consumer Business Unit from 2014 to 2017, as Chief Financial Officer and Vice President, IT Services Business Unit from 2012 to 2014, as Vice President, Finance Systems from 2011 to 2012, and as Vice President and Corporate Controller from 2008 to 2011.

Pamela Bailey

Ms. Pamela G. Bailey is Independent Director of the Company. Ms. Bailey has been President and Chief Executive Officer of The Grocery Manufacturers Association (“GMA”), a Washington, D.C. based trade association, since January 2009. From April 2005 until January 2009, she was President and Chief Executive Officer of the Personal Care Products Council. Ms. Bailey served as President and Chief Executive Officer of the Advanced Medical Technology Association (“AdvaMed”), the world’s largest association representing the medical technology industry, from June 1999 to April 2005. From 1970 to 1999, she served in the White House, the Department of Health and Human Services and other public and private organizations with responsibilities for health care public policy. Ms. Bailey is a director of the Reagan-Udall Foundation, a 501(c)(3) organization created by Congress to advance the mission of the Food and Drug Administration by advancing regulatory science and research. She formerly served as a director of Albertsons, Inc., MedCath Corporation, and The National Food Laboratory, Inc.

James Hinrichs

Mr. James F. Hinrichs serves as Independent Director of the company. Mr. Hinrichs served as Executive Vice President and Chief Financial Officer of Alere, Inc. from April 2015 until its sale to Abbott Labs in October 2017. From December 2010 through March 2015, he served as Chief Financial Officer of CareFusion Corporation prior to its sale to Becton Dickinson. Mr. Hinrichs previously served as CareFusion’s Senior Vice President, Global Customer Support, and as its Senior Vice President, Controller. Prior to joining CareFusion upon its spin off from Cardinal Health, Inc., he worked for five years at Cardinal Health in various positions including Executive Vice President and Corporate Controller of Cardinal Health and as Executive Vice President and Chief Financial Officer of its Healthcare Supply Chain Services segment. He joined Cardinal Health following more than a decade of finance and marketing roles at Merck & Co. He is a director of Orthofix International N.V. and serves as chair of its Audit and Finance Committee and a member of its Nominating & Governance Committee.

Jean Hobby

Ms. Jean Hobby is Independent Director of the Company. Ms. Hobby served as a global strategy partner at PricewaterhouseCoopers, LLP from 2013 until she retired in June 2015 following a 33 year career at that firm. Prior to 2013, Ms. Hobby served as PricewaterhouseCoopers’ Technology, Media and Telcom Sector Leader from 2008 to 2013, and as its Chief Financial Officer from 2005 to 2008. She joined PricewaterhouseCoopers in 1983 and became a partner in 1994. Ms. Hobby is also a director of Texas Instruments Incorporated and serves on its Audit Committee, and CA, Inc. and serves on its Audit Committee. The depth and breadth of Ms. Hobby’s 33 years of experience in global operations and financial and accounting matters support her continued service as a member of the Board.

Martin Maxwell

Mr. Martin Craig Maxwell is Independent Director of the Company. Mr. Maxwell is the Vice President and Chief Technology and Innovation Officer for Parker Hannifin Corporation, a Fortune 250 company located in Cleveland, Ohio that is one of the global leaders in motion and control technologies and systems, providing precision-engineered solutions for a variety of mobile, industrial, medical and aerospace markets. Mr. Maxwell’s responsibilities include leading Parker Hannifin in new and emerging markets and implementing Parker Hannifin’s new product development process. Additionally, Mr. Maxwell is responsible for Parker Hannifin’s technology incubator designed to facilitate cross group opportunities that leverage the company’s portfolio of products and technology to develop emerging opportunities. As Vice President and Chief Technology and Innovation Officer for Parker Hannifin, Mr. Maxwell leads that company’s innovation research that commercializes new technologies. Through this service, he has gained management experience at senior levels. These attributes provide the Company valuable insight into developing new technologies to support future growth and support Mr. Maxwell’s continued service on the Board.

Filippo Passerini

Mr. Filippo Passerini is Independent Director of the Company. Mr. Passerini is an Operating Executive in U.S. Buyouts for the Carlyle Group, a company he joined in July of 2015 following his retirement from a 33-year career at the Procter & Gamble Company. He joined Procter & Gamble in 1981 and held executive positions in Italy, Turkey, United Kingdom, Greece, Latin America and the United States. Prior to his retirement, Mr. Passerini served as Procter & Gamble’s Group President, Global Business Services and Chief Information Officer, positions he held from 2004 and 2005, respectively. He oversaw over 170 distinct services in 70 countries and led the integration of Procter & Gamble’s IT and Business Services groups, one of the largest shared services organizations in the world. Mr. Passerini is a director of United Rentals, Inc. and serves on its Audit and Compensation Committees, and of ABM Industries Incorporated and serves as Chair of its Strategy & Enterprise Risk Committee and a member of its Compensation Committee.

Peter Soderberg

Mr. Peter H. Soderberg is Independent Director of the Integer Holdings Corp. Mr.Soderberg is managing partner of Worthy Ventures Resources, LLC, a private investment company he founded in February 2010. He retired in January 2010 as President and Chief Executive Officer of Hill-Rom Holdings, Inc. (formerly Hillenbrand Industries), a position he held since March 2006. From January 2000 to March 2006, he was President and Chief Executive Officer of Welch Allyn, Inc., and for the seven years prior to that, Chief Operating Officer of Welch Allyn’s medical products business. Mr. Soderberg also held a number of positions over a twenty-three year career with Johnson & Johnson, where his final position was as president of one of its operating subsidiaries. Until his retirement, he also had served on the board of directors of Hill-Rom and AdvaMed. Mr. Soderberg currently serves as a Director of St. Vincent Health System (Indianapolis), as well as of several privately-held medtech companies. He is a former director of Constellation Brands, Inc. and Welch Allyn.

Donald Spence

Mr. Donald J. Spence is Independent Director of the Company., effective October 17, 2016. Mr. Spence brings 40 years of experience, including over 25 years in the medical device industry, in operations, finance and general management roles to our Board. He most recently served as chairman and chief executive officer of Lake Region Medical Holdings, Inc. from 2010 until its acquisition by the Company in October of 2015. From 2005 to 2008, he served as president of the Sleep and Home Respiratory Group for Philips Respironics, and from 2008 to 2010 as chief executive officer of Philips Home Healthcare Solutions. Prior to that, Mr. Spence spent eight years with GKN Sinter Metals, as senior vice president for global sales and marketing (1998-2001) and as president (2001-2005). Before 1998, he served in a number of roles at BOC Group, PLC over a 15-year career at that company. Mr. Spence serves on the board of directors of two privately held Medtech companies.

William Summers

Mr. William B. Summers, Jr. is Independent Director of the Company. Mr. Summers retired in June 2006 as Chairman of McDonald Investments Inc., a position he had held since 1998. He also held the additional positions of President (from 1989 through 1998) and Chief Executive Officer (from 1994 through 1998) of that investment company. Mr. Summers serves on the board of directors of RPM International, Inc. and is a member of its audit committee. He also serves on the advisory boards of Molded Fiberglass Companies and Citymark Capital, and on the board of The Rock and Roll Hall of Fame and Museum, Baldwin-Wallace University, United States Army War College Foundation, and the Convention and Visitors Bureau of Greater Cleveland, Inc. Mr. Summers previously served as chairman of the board of the National Association of Securities Dealers, as chairman of the board of the NASDAQ Stock Market, and as a director of NYSE. He is a former director of Developers Diversified Realty, Inc., McDonald Investments Inc., Cleveland Indians Baseball Company, and Penton Media Inc.

Tony Borowicz